This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BIOA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sales of Leqembi® totaled 23.1 billion yen in the second quarter 2025August 1, 2025 | finance.yahoo.comLecanemab four-year efficacy and safety data to be presented at AAIC 2025July 22, 2025 | finance.yahoo.comBioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific SessionsJune 21, 2025 | globenewswire.comBioage Labs Inc BIOAJune 20, 2025 | morningstar.comMBioAge Labs, Inc. Common Stock (BIOA)June 18, 2025 | nasdaq.comBioAge Labs Expands Drug Discovery Platform with Data from Leading European BiobankJune 17, 2025 | globenewswire.comBioAge Labs completes IND-enabling studies for BGE-102May 30, 2025 | finance.yahoo.comBioAge Labs, Inc. (BIOA)’s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025May 29, 2025 | insidermonkey.comBioAge Labs to Present at Upcoming Investor ConferencesMay 27, 2025 | globenewswire.comBioArctic AB: Bulletin from the Annual General Meeting in BioArctic AB (publ)May 23, 2025 | finanznachrichten.deBIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmMay 21, 2025 | globenewswire.comEisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026)May 15, 2025 | finance.yahoo.comInvitation to presentation of BioArctic's first quarter report for January - March 2025 on May 21 at 9.30 a.m. CETMay 13, 2025 | finance.yahoo.comBioArctic: Exidavnemab phase 2a study expanded to include MSA patientsMay 8, 2025 | finanznachrichten.deExidavnemab phase 2a study expanded to include MSA patientsMay 8, 2025 | finance.yahoo.comWith 44% stake, BioAge Labs, Inc. (NASDAQ:BIOA) seems to have captured institutional investors' interestMay 6, 2025 | finance.yahoo.comBioAge Labs Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 6, 2025 | globenewswire.comThe European Commission refers lecanemab decision to Appeal CommitteeApril 1, 2025 | finance.yahoo.comJefferies Reaffirms Their Hold Rating on BioAge Labs, Inc. (BIOA)March 23, 2025 | markets.businessinsider.comBioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024March 20, 2025 | globenewswire.comFinal Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOAMarch 10, 2025 | prnewswire.comBIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities LawsuitMarch 10, 2025 | prnewswire.comBIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOAMarch 10, 2025 | globenewswire.comLost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyMarch 10, 2025 | globenewswire.comBIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged to Contact BFA Law before the Expiration of Today's Class Action DeadlineMarch 10, 2025 | globenewswire.comBioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOAMarch 10, 2025 | prnewswire.comBIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 10, 2025 | prnewswire.comBIOA DEADLINE TOMORROW: BioAge Labs Investors are Notified to Contact BFA Law before Tomorrow's March 10 Class Action DeadlineMarch 9, 2025 | markets.businessinsider.comBIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action LawsuitMarch 8, 2025 | theglobeandmail.comBIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - Contact BFA Law if You Suffered LossesMarch 8, 2025 | globenewswire.comDeadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitMarch 7, 2025 | tmcnet.comBIOA LEGAL NOTICE: BioAge Labs Investors are Notified of Upcoming Class Action Deadline and are Urged to Contact BFA LawMarch 7, 2025 | markets.businessinsider.comBioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit -- Hagens BermanMarch 7, 2025 | gurufocus.comBioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens BermanMarch 7, 2025 | globenewswire.comBIOA Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action LawsuitMarch 7, 2025 | globenewswire.comLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc. (BIOA) ShareholdersMarch 7, 2025 | globenewswire.comBIOA DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOAMarch 7, 2025 | globenewswire.comFaruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOAMarch 7, 2025 | globenewswire.comMONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIOAMarch 7, 2025 | globenewswire.comBIOA Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action LawsuitMarch 6, 2025 | prnewswire.comBioAge Labs, Inc. (BIOA) Initiated with a Hold at William BlairMarch 6, 2025 | markets.businessinsider.comINVESTOR DEADLINE MONDAY: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIOAMarch 6, 2025 | prnewswire.comThe Gross Law Firm Notifies Shareholders of BioAge Labs, Inc. (BIOA) of a Class Action Lawsuit and an Upcoming DeadlineMarch 6, 2025 | globenewswire.comBioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitMarch 6, 2025 | prnewswire.comBIOA INVESTOR LAWSUIT: A Class Action has been filed on behalf of BioAge Labs Investors – Contact BFA Law before the March 10 Court DeadlineMarch 6, 2025 | globenewswire.comThe Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming DeadlineMarch 6, 2025 | prnewswire.comBIOAGE LABS (BIOA) Investors have until March 10 before the Expiration of the Class Action Deadline and are Urged to Contact BFA LawMarch 5, 2025 | markets.businessinsider.comBioAge Labs, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 10, 2025 Deadline to file Lead Plaintiff MotionMarch 5, 2025 | globenewswire.comBIOA Deadline: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities LawsuitMarch 5, 2025 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge LabsMarch 5, 2025 | prnewswire.com Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOA Media Mentions By Week BIOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOA News Sentiment▼0.000.75▲Average Medical News Sentiment BIOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOA Articles This Week▼06▲BIOA Articles Average Week Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MBX Biosciences News Aerovate Therapeutics News Cybin News Virios Therapeutics News PyroGenesis Canada News Eliem Therapeutics News Actinium Pharmaceuticals News OS Therapies News Aadi Bioscience News Eagle Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIOA) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access